Subscribe to our Newsletters !!

    Transcriptomics

    Drug discovery pipeline to exploit transcription factors for cancer therapy

    Cancer is a major cause of death and among the most complicated challenges to contemporary medication. By employing cutting-edge technologies that precisely measure the effects of candidate targets and drugs on the fundamental process of transcription, the new start-up firm QUANTRO Therapeutics tries to radically change the precision and range of cell-based drug screening. QUANTRO’s

    Bruker presents Vutara™ VXL tbest-in-class super-resolution magnifying lens and spatial science investigation abilities

    Vutara VXL serves as a biological microscopy workstation for research on DNA, RNA and proteins, from macromolecular complexes and super-structures, to chromatin structure and chromosomal substructures, to studying functional connections in genomes and in various subcellular organelles. This novel system supports innovative spatial biology research in extracellular matrix structures, extracellular vesicles (EV), virology, neuroscience, and

    Researchers describe the systems that manage embryonic stem cells

    Scientists at the Proteomics Core Unit of the Spanish National Cancer Research Centre (CNIO), headed by Javier Muñoz, have clarified the mechanisms, unknown to date, included in maintaining embryonic stem cells in the best possible condition for their use in regenerative medicine. The results, published in Nature Communications, helps to find novel stem-cell therapies for